• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2000224 IBI102 IBI102 Injection Biological Products(1) New Drug Application 2020-08-04 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-08-03 view
CXSL1900040 IBI110 IBI110 Other Biological Products(1) New Drug Application 2019-04-26 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2019-04-25 view
CXSL2000021 IBI112 IBI112 Injection Biological Products(1) New Drug Application 2020-02-14 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-02-13 view
CXSL2000049 IBI112 IBI112 Injection Biological Products(1) New Drug Application 2020-03-14 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-03-13 view
CXSL2000263 IBI188 letaplimab Injection Biological Products(1) New Drug Application 2020-09-12 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-09-11 view
CXSL1800074 IBI188 letaplimab Injection Biological Products(1) New Drug Application 2018-07-04 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2018-09-03 view
CXSL1900053 IBI306 tafolecimab Injection Biological Products(1) New Drug Application 2019-06-12 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2019-06-10 view
CXSL1500136 IBI308 sintilimab Injection Biological Products(1) New Drug Application 2016-01-25 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-09-04 view
CXSL2000233 IBI310 ipilimumab Injection Biological Products(3.3) New Drug Application 2020-08-12 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-08-11 view
CXSL2000222 IBI310 ipilimumab Injection Biological Products(3.3) New Drug Application 2020-08-04 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-08-03 view
CXSL2000231 IBI310 ipilimumab Injection Biological Products(3.3) New Drug Application 2020-08-12 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-08-11 view
CXSL2100029 IBI318 IBI318 Injection Biological Products(1) New Drug Application 2021-01-23 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-22 view
CXSL2000304 IBI318 IBI318 Injection Biological Products(1) New Drug Application 2020-10-28 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-10-27 view
CXSL2000274 IBI318 IBI318 Injection Biological Products(1) New Drug Application 2020-09-28 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-09-28 view
CXSL1800119 IBI318 IBI318 Injection Biological Products(1) New Drug Application 2018-12-10 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2018-12-07 view
CXSL2000255 IBI319 IBI319 Injection Biological Products(1) New Drug Application 2020-09-05 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-09-04 view
CXSL2100081 IBI321 IBI-321 Injection Biological Products(1) New Drug Application 2021-03-04 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-03-03 view
CXSL1900125 IBI322 IBI322 Injection Biological Products(1) New Drug Application 2019-11-07 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2019-11-06 view
CXSL2000242 IBI323 IBI323 Injection Biological Products(1) New Drug Application 2020-08-25 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2020-08-24 view
CXHL2100071 IBI362注射液 mazdutide Injection Chemical Drugs(1) New Drug Application 2021-01-29 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-28 view